Americas' opioid/psychostimulant epidemic would benefit from general population early identification of genetic addiction risk especially in children of alcoholics (COAs)
1 Western University Health Sciences, Graduate School of Biomedical Sciences, Pomona, CA, USA.
2 Division of Addiction Services, Dominion Digagnostics, LLC., North Kingstown, RI, USA.
3 Division of Nutrigenomics, Geneus Health LLC., San Antonio, TX, USA.
4 Division of Nutrigenomics, Victory International, Inc., Lederach, PA, USA.
5 Department of Psychiatry, University of Vermont, Burlington, VM, USA.
6 Divion of Neuroscience and Addiction Research, Pathway HealthCare, LLC., Birmingham, AL, USA.
7 Behavioral Neuropharmacology and Neuroimaging Laboratory on Addiction, Research Institute on Addictions, University of Buffalo, Buffalo, NY, USA.
8 Claudia Black Young Adult Center, Wickenburg, AZ, USA.
9 Department of Psychology, Curry College, Milton MA, USA.
10 Department of Psychiatry, South Texas Veteran Health Care System, Audie L. Murphy Memorial VA Hospital, San Antonio, TX, Long School of Medicine, University of Texas Medical Center, San Antonio, TX, USA.